Chinese researchers found that people infected with the Delta variant carry 1,260 times more virus in their noses compared to those infected in the first wave of the pandemic.
Boxes of Walvax Biotechnology's mRNA COVID-19 vaccine are displayed at a trade fair in Shanghai - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19.Most people with allergic reactions to the first dose of an mRNA COVID-19 vaccine from either Pfizer/BioNTech or Moderna can safely receive the second dose, a new study shows.
Chinese researchers tracking a recent COVID-19 outbreak in China found that people infected with the Delta variant carry 1,260 times more virus in their noses compared to those infected in the first wave of the pandemic. The higher load means the virus spreads far more easily from person to person, increasing infections and hospitalizations, they reported ahead of peer review in a paper first posted on medRxiv earlier in July and updated on Friday https://bit.ly/3iNDQPR.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
After Covid jab, BioNTech sets sights on malaria vaccineGermany's BioNTech, which developed a coronavirus vaccine with US giant Pfizer in record time, said Monday it aimed to start trialling a malaria vaccine next year using the same breakthrough mRNA technology.
Read more »
BioNTech aims to develop mRNA-based malaria vaccineBERLIN: BioNTech wants to build on its success in COVID-19 by developing the first vaccine for malaria based on mRNA technology and aims to start ...
Read more »
Antibodies from Sinovac's COVID-19 shot fade after about 6 months, booster helps: StudyBEIJING: Antibodies triggered by Sinovac's COVID-19 vaccine decline below a key threshold from around six months after a second dose for most ...
Read more »
Mixed AstraZeneca-Pfizer shot boosts COVID antibody level - studyA mixed vaccination of first AstraZeneca and then a Pfizer COVID-19 shot boosted neutralizing antibody levels by six times compared with two AstraZeneca doses, a study from South Korea showed. The study involved 499 medical workers - 100 receiving mixed doses, 200 taking two doses of the Pfizer/BioNTech shot and the remainder getting two AstraZeneca shots. All showed neutralizing antibodies, which prevent the virus from entering cells and replicating, and the result of the mixed schedule of vaccines showed similar amounts of neutralizing antibodies found from the group that received two Pfizer shots.
Read more »
Not yet time to consider making Covid-19 vaccination mandatory: Ong Ye KungSINGAPORE — It is not yet time for the Government to think about making Covid-19 jabs mandatory as they are being rolled out under emergency authorisation, though perhaps it is a policy that “governments around the world will have to consider” when Covid-19 becomes endemic, Health Minister Ong Ye Kung said on Monday (July 26).
Read more »
Malaysia has more than 1,000 Covid-19 patients in ICU for first timeKUALA LUMPUR, July 26 — Malaysia racked up another new record today as 1,009 Covid-19 patients were sent to intensive care units (ICUs) today. It’s the first time since the pandemic begun that...
Read more »